Navigation Links
Healthcare Sector Announced Clinical Data Presentation, Upcoming Financial Release Schedules and Updates on New Drug Applications - Research Report on Alexion, Pacira, pSivida, Momenta and Impax
Date:10/23/2013

NEW YORK, October 23, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

Today, Analysts' Corner announced new research reports highlighting Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), Pacira Pharmaceuticals Inc. (NASDAQ: PCRX), pSivida Corp. (NASDAQ: PSDV), Momenta Pharmaceuticals Inc. (NASDAQ: MNTA) and Impax Laboratories Inc. (NASDAQ: IPXL). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Alexion Pharmaceuticals, Inc. Research Report

On October 16, 2013, Alexion Pharmaceuticals (Alexion) announced that its researchers are scheduled to present data from clinical studies of Soliris (eculizumab) in patients with atypical hemolytic uremic syndrome (aHUS), at the annual meeting of the American Society of Nephrology (ASN), to be held from November 5, 2013 to November 10, 2013, in Atlanta, Georgia. The Company informed that that aHUS is a genetic, life-long, ultra-rare disease associated with vital organ failure and premature death. Alexion stated that the presentation will include: results from a prospective clinical trial of Soliris in pediatric patients with aHUS, following the published results of a retrospective study in pediatric patients with aHUS; results from an expanded adult population, representing the largest prospective trial of Soliris in adult patients with aHUS; and three-year follow-up data from two pivotal Phase 2 extension studies that highlight the long-term benefits of Soliris therapy in p
'/>"/>

SOURCE Analysts' Corner
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ViiV Healthcare announces US regulatory submission for a single-tablet regimen combining dolutegravir with abacavir and lamivudine for people living with HIV
2. Global Healthcare Leader Deploys QUOSAs Literature Management Tools
3. Sysmex America Leads Educational Offerings Focused on Healthcare Reforms Impact on the Clinical Laboratory
4. Hyland Software Partners with the Global Center for Healthcare Innovation in Cleveland
5. Allied Healthcare Products Reports Loss On Sales Decline
6. 50 Years Old and Still Bounding Over the Counter: Klines Healthcare Practice Continues to Deliver Unmatched OTC Market Intelligence
7. Experian Healthcare launches tool to enable providers to identify and help enroll eligible individuals for health insurance exchange (HIX) subsidized programs
8. BioSpecifics Technologies Corp. to Present at the Aegis Capital 2013 Healthcare Conference
9. Orange County Hospital System, Integrated Healthcare Holdings, Joins ApolloMed ACO
10. ViiV Healthcare Presents Positive Data from Phase IIIb/IV Study of Dolutegravir vs Darunavir in Treatment-Naive Adults with HIV-1
11. Hubble Telemedical Welcomes Healthcare Visionary Jonathan Lord, M.D. to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Sept. 17, 2014  Aratana Therapeutics, Inc. (NASDAQ: ... on licensing, developing and commercializing innovative biopharmaceutical products ... its public offering of 4,500,000 shares of its common stock ... per share. Aratana has granted the underwriters a ... 675,000 shares of its common stock. ...
(Date:9/17/2014)... Cardiac Dimensions ® , Inc. today announced ... II clinical trial of its enhanced CARILLON Mitral ... mitral regurgitation, functional improvement, quality of life and ... data, which was consistent with previous trials of ... 26 th annual Transcatheter Cardiovascular Therapeutics Conference ...
(Date:9/17/2014)... , Sept. 17, 2014  Neuraltus Pharmaceuticals, Inc. announced ... 2 clinical program of NP001 for the treatment of ... disease) are being highlighted today in an oral presentation ... Group , being held in Bloomington, Minnesota ... hoc  analysis, administration of a high dose of NP001 ...
Breaking Medicine Technology:Aratana Therapeutics, Inc. Announces Pricing of Public Offering 2Cardiac Dimensions Announces New Long-Term Outcomes Data From TITAN II Clinical Trial Demonstrates Safety, Efficacy Of Enhanced CARILLON Mitral Contour System 2Cardiac Dimensions Announces New Long-Term Outcomes Data From TITAN II Clinical Trial Demonstrates Safety, Efficacy Of Enhanced CARILLON Mitral Contour System 3Neuraltus Pharmaceuticals' ALS Treatment Candidate, NP001, Highlighted at ALS Research Group Summit 2Neuraltus Pharmaceuticals' ALS Treatment Candidate, NP001, Highlighted at ALS Research Group Summit 3
... Texas, Sept. 26, 2011 Vermillion, Inc. ... today announced the appointment of Donald Munroe, Ph.D. as ...  He will be responsible for furthering development of Vermillion,s ... continue the preclinical studies and initiate appropriate clinical studies ...
... SAN DIEGO, Sept. 26, 2011 Elevation Pharmaceuticals, Inc., ... aerosol therapies for patients with respiratory diseases, today announced ... and Chief Business Officer and Pravin Soni, PhD, as ... created positions. The company also announced that it drew ...
Cached Medicine Technology:Vermillion Enhances Management Team With A Key Addition 2Vermillion Enhances Management Team With A Key Addition 3Vermillion Enhances Management Team With A Key Addition 4Elevation Pharmaceuticals Strengthens Management Team with Appointment of Executives 2Elevation Pharmaceuticals Strengthens Management Team with Appointment of Executives 3
(Date:9/17/2014)... 17, 2014 (HealthDay News) -- A blood test that ... doctors with a better assessment of the state of ... If used routinely, this blood test could reveal when ... actually begins promoting tumor growth, the researchers suggested. ... patients with advanced prostate cancer and often initially very ...
(Date:9/17/2014)... this month for the November elections, one of the ... out the chamber door will be the Sustainable Growth ... of 2014. In a new commentary in the journal ... he and other advocates saw as the merits of ... Medicare pays doctors will return for the next Congress, ...
(Date:9/17/2014)... (PRWEB) September 18, 2014 Many countries ... influenza, instead of immunizations. The total number of poultry ... difficult to control, will result in huge losses. Therefore, ... avian influenza vaccines. , Avian influenza vaccines have been ... poultry farms in China began to use H5N1 avian ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Smart Flour ... Picks by Progressive Grocer, a leading trade magazine targeted ... awarded for originality and flavor, among other attributes. Smart ... an Editor’s Pick in the September print issue of ... website. , The pizza won based on its superior ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 A petition ... ) in laparoscopic hysterectomies and other gynecological surgeries has ... to figures posted on Change.org, at least 84,908 supporters ... , According to a recent report from ABC News, ... by Dr. Hooman Noorchashm, after his wife, Dr. Amy ...
Breaking Medicine News(10 mins):Health News:DNA Blood Test Might Identify Status of Prostate Cancer 2Health News:Failed Medicare payments law remains relevant 2Health News:Failed Medicare payments law remains relevant 3Health News:China Avian Influenza Vaccine Industry 2014-2018 Research Report Now Available at LifeScienceIndustryResearch.com 2Health News:China Avian Influenza Vaccine Industry 2014-2018 Research Report Now Available at LifeScienceIndustryResearch.com 3Health News:Smart Flour Foods Wins 2014 Progressive Grocer Editor’s Pick Award 2Health News:Power Morcellator Petition Nears 85,000 Signatures, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Petition Nears 85,000 Signatures, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Petition Nears 85,000 Signatures, Bernstein Liebhard LLP Reports 4
... American Associations for Dental Research announced that its Journal ... Five-Year Scientific Impact Factor (SIF) from 4.195 to 4.389. In ... #1 in Article Influence. This news comes from the new ... Journal Citation Reports (JCR). This latest report also shows that ...
... researchers from Boston University School of Medicine (BUSM) and ... high rate of thyroid function testing in pregnant women. ... the Journal of Clinical Endocrinology & Metabolism , ... testing on pregnant women, approximately 80 percent of cases ...
... has discovered in young adult mice that a lone brain stem ... to specialized neurons and glia important types of brain cells ... new brain stem cells. A report on their study appears ... that the brain has the capacity to generate both neurons, which ...
... HealthDay Reporter , THURSDAY, June 30 (HealthDay News) -- The ... rooms for drinking-related injuries doubles over the July 4th weekend, ... sends a daily average of nearly 1,000 youth under 21 ... problems related to alcohol use, according to a report by ...
... Italy, 30 June 2011 Differences in male and female ... be more verbally fluent, have better manual dexterity and are ... the other hand often take less time parking their cars ... new city. The latter capacities, in which men tend to ...
... Insomnia is the most prevalent sleep disorder, affecting ... the United States on a weekly basis. ... ever, randomized, controlled clinical research study in the country ... Optimization is a non-invasive technology that helps the brain ...
Cached Medicine News:Health News:Journal of Dental Research increases its scientific impact factor 2Health News:BMC conducts high rates of thyroid testing in pregnant women, study finds 2Health News:Nervous system stem cells can replace themselves, give rise to variety of cell types, even amplify 2Health News:July 4 Weekend Dangerous for Underage Boys Who Drink: Report 2Health News:Sound localization at cocktail parties is easier for men 2Health News:Wake Forest Baptist conducts clinical study for insomnia using new technology 2
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medicine Products: